into APC, an effect that is facilitated by the endothelial protein C receptor (EPCR).
APC acts as an anticoagulant, together with its co-factor protein S (PS), by inactivating factors Va and VIIIa, and in addition exerts profibrinolytic effects through inhibition of plasminogen activator inhibitor type I (PAI-1), the main inhibitor of plasminogen activation. Moreover, several anti-inflammatory effects have been ascribed to APC, including inhibition of leukocyte activation, inhibition of Eselectin mediated cell adhesion to the vascular endothelium and reduction of tumor necrosis factor (TNF)-production [3] [4] [5] [6] [7] [8] .
Evidence exists that exogenously administered APC can inhibit inflammatory responses in the pulmonary compartment. Intravenous infusion of APC protected against lung injury by inhibiting leukocyte activation in rats challenged with lipopolysaccharide (LPS) systemically 9 and direct intrapulmonary delivery of APC reduced allergic and bleomycin-induced lung inflammation in mice 10, 11 . Moreover, in a very recent study in healthy humans intravenous administration of APC resulted in a reduced neutrophil influx into lung subsegments challenged with LPS 12 . Considering that TM is abundantly expressed in the lungs [13] [14] [15] 
MATERIALS AND METHODS

Animals
Mice with a single amino acid substitution (Glu 404 -> Pro) in the gene for TM, kindly provided by dr. R.D. Rosenberg (Massachusetts Institute of Technology, Cambridge, Massachusetts) were generated on a C57BL/6 (and B6D2F1) background, as previously described 16 . Homozygous mutant TM pro/pro mice exhibit a decrease of approximately 1000-fold with respect to PC activation and approximately 100-fold with respect to binding of thrombin at physiological levels of the enzyme 16 . In addition, TM pro/pro mice produce < 4% of APC in their alveolar space generated by WT mice upon intratracheal administration of PC and thrombin 15 . Yet in contrast to TM gene deficient mice, which die in the embryonic stage 19 , TM pro/pro mice develop to term, and possess normal reproductive performance 16 . All mice were on a C57BL/6 background. The WT of the TM pro/pro mice were derived from original littermates and in all studies mice from the same generation were used. All experiments were approved by the Committee on Use and Care of Animals of the Academic Medical Center, Amsterdam, the Netherlands.
Experimental infection
Pulmonary tuberculosis was induced exactly as described previously [20] [21] [22] 
Lung cell counts and differentiation
Pulmonary-cell suspension was obtained using an automated disaggregation device (Medimachine System; DAKO A/S, Glostrup, Denmark) as described [20] [21] [22] 
Histologic examination
After 24h fixation of lungs in 10% formaline and embedding in paraffin, 4 µm thick sections were stained with haematoxylin and eosin (H&E) and Ziehl Nielsen (ZN).
All slides were coded and scored by a pathologist without knowledge of the genotype of mice and treatment. Staining for granulocytes, macrophages, fibrin(ogen) and TM was done exactly as decribed 15, [23] [24] [25] . In brief for TM staining, after quenching endogenous peroxidase activity and blocking non-specific binding, slides were incubated with a rat anti-mouse TM mAb (kindly provided by Dr. S.J. Kennel, Oak
Ridge National Laboratory, Oak Ridge) followed by a biotinylated rabbit anti-rat polyclonal Ab (Dako). Slides were then incubated in a streptavidin-ABC solution (Dako) and developed using 1% H 2 O 2 and 3.3'-diaminobenzidin-tetra-hydrochloride (Sigma) in Tris-HCl. The sections were mounted in glycerin gelatin after a slight methyl green counterstaining.
FACS analysis
For FACS analysis pulmonary cell suspensions were obtained using an automated disaggregation device (Medimachine System; Dako, Glostrup, Denmark) and processed as described previously [20] [21] [22] . Cells were brought to a concentration of 4 x 10 6 cells/ml FACS buffer (PBS supplement with 0.5% BSA, 0.01% NaN 3 , and 100 mM EDTA). Immunostaining for cell surface molecules was performed for 30 min at 4°C using directly labeled Abs against CD3, CD4, CD25, CD69, Ly-6 (Gr-1) and 
Assays
Thrombin-antithrombin complexes (TAT-c) were measured by ELISA as described 15, 24 . 
Statistical analysis
Data are expressed as means ± SEM, unless indicated otherwise. Comparisons between groups were conducted using the Mann Whitney U test. For comparison of survival curves, Kaplan-Meier analysis with a log rank test was used. P < 0.05 was considered to represent a statistically significant difference.
only.
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RESULTS
TM-expression
We previously reported that TM expression becomes down regulated in lung tissue during the acute inflammatory response to intranasally administered bacteria or LPS 15 , which is in line with earlier findings of reduced TM expression in the dermal microvasculature of patients with severe bacterial sepsis 26 . To obtain insight into the regulation of TM expression in the lung during chronic infection, we compared the expression of TM in lungs obtained from uninfected mice and from mice 5 weeks after intranasal infection with M. tuberculosis using anti-TM immunostaining. As shown in Figure 1 , a dramatic reduction of TM immunoreactivity was observed 5
weeks after infection in WT ( Figure 1B ) and TM pro/pro mice ( Figure 1C ) compared to uninfected mice ( Figure 1A ).
No evidence for coagulation activation in TM pro/pro mice
Tuberculosis can be associated with a modest procoagulant state, which occasionally even can result in disseminated intravascular coagulation 27, 28 . Since the TM pro/pro mutation results in a mild prethrombotic state 16 , we wondered whether endogenous For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From pneumonia (4.0 ± 0.3 ng/mL), indicating that this assay is able to detect thrombin generation in these samples. Thus, these data argue against a role for TM-APC in preventing coagulation during tuberculosis.
TM pro/pro mice show uncontrolled pulmonary inflammation
Next we evaluated whether the TM pro/pro mutation influenced the inflammatory response in the lung during tuberculosis. Remarkably, whereas at 2 weeks postinfection lung weights were similar in both mouse strains (data not shown), at 5 weeks after inoculation with M. tuberculosis the lung weights of TM pro/pro mice were much higher than those of WT mice (right lungs: 307 ± 10 versus 188 ± 19 mg respectively, P < 0.05), indicative for enhanced inflammation and edema. In line with these findings, histopathological examination of lung tissue did not reveal differences between TM pro/pro and WT mice at 2 weeks postinfection (not shown). However, profound differences were found between TM pro/pro and WT mice at 5 weeks after infection ( Figure 3) . Indeed, at that time point, lungs of WT mice displayed granulomatous inflammatory infiltrates primarily located around small bronchi and vessels ( Figure 3A ) composed of lymphocytes and macrophages ( Figure 3G ) with few granulocytes ( Figure 3E ), confirming earlier observations [20] [21] [22] . In contrast, lungs of TM pro/pro mice displayed more confluent areas of inflammation ( Figure 3B) predominantly composed of neutrophils ( Figure 3F ) and foamy macrophages ( Figure   3H ). Moreover, edema and pleuritis were more pronounced in TM pro/pro than in WT mice.
TM pro/pro mice show increased neutrophil influx into lungs
To obtain more insight into the cellular composition of the pulmonary infiltrates in TM pro/pro and WT mice, we prepared whole lung suspensions at 2 and 5 weeks after infection (Table I) . At 2 weeks, TM pro/pro and WT mice had similar leukocyte numbers in their lungs, albeit lungs of the former mouse strain already contained more neutrophils (P < 0.05 versus WT). At 5 weeks after infection, the lungs of TM pro/pro mice contained more leukocytes (P = 0.07 versus WT), which was caused by a profound rise in the number of neutrophils (P < 0.05 versus WT). Interestingly, this enhanced neutrophil influx was accompanied by the presence of less lymphocytes and macrophages in lungs of TM pro/pro mice (both P < 0.05 versus WT). To determine whether the diminished influx of lymphocytes in TM pro/pro mice was restricted to a certain subset, we analyzed whole lung cell suspensions obtained 5 weeks postinfection by FACS (Table II) . This revealed that the percentages of CD4 + and CD8 + T-cells within the CD3 + population did not differ between TM pro/pro and WT mice. Moreover, in both strains the CD4 + and CD8 + T-cells equally expressed the activation markers CD25 and CD69. Finally, we also evaluated the activation status of Gr-1+ neutrophils in the lungs by analyzing CD11b expression, and found no differences between TM pro/pro and WT mice.
TM pro/pro mice have elevated levels of proinflammatory cytokines and reduced levels of anti-inflammatory cytokines in lungs
Cytokines and chemokines play a pivotal role in the regulation of the immune response to tuberculosis 18, 29, 30 . Therefore, we measured the concentrations of proinflammatory (IFN-, TNF-) and anti-inflammatory cytokines (IL-4, IL-10, TGF-) in lung homogenates obtained 2 and 5 weeks after infection (Table III) . At 2 weeks only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From postinfection, the pulmonary concentrations of these mediators were similar in TM pro/pro and WT mice. However, at 5 weeks TM pro/pro mice displayed increased levels of IFN-and TNF-in their lungs when compared to WT mice (P < 0.05), whereas the lung levels of IL-4, IL-10 and TGF-were lower in TM pro/pro mice at that time point. In light of the altered recruitment of inflammatory cells to the pulmonary compartment in TM pro/pro versus WT mice, we also measured MCP-1 (a prototypic CC chemokine) and MIP-2 (a major CXC chemokine with neutrophil attracting properties) 31 . Both MCP-1 and MIP-2 concentrations were higher in TM pro/pro than in WT mice (P < 0.05).
TM pro/pro mice have a modestly decreased bacterial outgrowth
We next determined the role of the TM pro/pro mutation in containing the bacterial 
TM pro/pro mice succumb to prolonged mycobacterial infection
Having established that TM pro/pro mice display an uncontrolled inflammatory response in their lungs 5 weeks after infection with M. tuberculosis, we next evaluated the consequences of the TM pro/pro mutation on the pulmonary inflammatory response to even more prolonged infection. For this 14 TM pro/pro and 14 WT mice were infected with a lower inoculum of M. tuberculosis (10 4 CFU) and followed for 36 weeks.
During the first 28 weeks of infection, none of the mice of either group died;
For weeks after infection with a higher inoculum, lung weights were much higher in TM pro/pro mice than in WT mice (right lungs: 493 ± 37 versus 326 ± 16 mg respectively, P < 0.05). Moreover, a profound difference was seen in the percentage of confluent inflammation of the lung, revealing more inflammation in the lungs of TM pro/pro mice than in the lungs of WT mice (84 ± 5 % versus 57 ± 4 % respectively, P < 0.05; representative slides shown in Figure 6 ). Moreover, the inflammatory infiltrate consisted mostly of lymphocytes in WT mice versus mostly foamy macrophages in TM pro/pro mice (inserts of Figure 6 ). In all surviving mice M.
tuberculosis could be cultured from lungs, liver and spleen. Whereas the mycobacterial burden in lungs of TM pro/pro mice and WT mice was similar, livers and spleens of TM pro/pro mice contained significantly more mycobacteria than livers and spleens of WT mice (Figure 7) .
For
DISCUSSION
The central aim of this study was to examine the influence of TM, in particular the domain of TM that is crucial for the generation of APC, in the regulation of the pulmonary response to tuberculosis. In theory, a reduced capacity to produce APC could influence the local response to chronic infection with M. tuberculosis via two major mechanisms: in light of the anticoagulant properties of APC, the TM pro/pro mutation could result in an increased tendency to form pulmonary thrombosis, whereas in light of the anti-inflammatory properties of APC, this TM mutation could lead to an enhanced proinflammatory reaction. We here demonstrate that TM pro/pro mice do not display a diminished capacity to maintain a normal hemostatic balance during tuberculosis, but clearly have a reduced ability to control the inflammatory response to M. tuberculosis infection.
The role of TM in disease cannot be investigated using TM gene deficient mice since these mice die in the embryonic phase 19 . Therefore, we used TM pro/pro mice, which
are viable yet have a strongly reduced capacity to produce APC. Indeed, TM pro/pro mice exhibit a 100-fold reduction with respect to binding of thrombin and a 1000-fold reduction with respect to PC activation in the circulation 16 . Similarly, TM pro/pro mice display a strongly reduced capacity to generate APC in their alveolar space (a 25-fold reduction when compared to WT mice) 15 . The incapacity of TM pro/pro mice to activate PC has been demonstrated using an indirect approach, i.e. mice received an intravenous 16 or intratracheal 15 dose of human PC with or without thrombin, after which human APC levels were determined in plasma or bronchoalveolar lavage fluid respectively using an immuno-capture assay. To the best of our knowledge, APC Although Sato et al. used a different pathogen, these data suggest that mycobacterial infection can be associated with modest fibrin generation in lungs; the fact mice with a deficient fibrinolysis showed clearly enhanced fibrin(ogen) deposition further supports the notion that the role of the TM in prevention thrombosis is not important.
Our inability to detect activation of coagulation in mice with tuberculosis was not due to an inadequate sensitivity of the fibrin staining, considering that exactly the same antibodies and procedures were used in our earlier investigations showing positive fibrin(ogen) staining in lungs of mice with either pneumonia caused by Streptococcus pneumoniae ( Figure 3I ) or Klebsiella pneumoniae, with sterile lung inflammation caused by LPS, or with Escherichia coli peritonitis 15, 24 . In addition, TAT-c levels did not rise during tuberculosis, whereas elevated lung homogenate levels were found in mice with pneumococcal pneumonia.
In contrast to the lack of an effect on coagulation, the TM pro/pro mutation exerted a profound effect on the inflammatory reaction to M. tuberculosis infection. Indeed, at 5 weeks after infection TM pro/pro mice displayed uncontrolled inflammation in their lungs, which was associated with a diminished capacity to form well-shaped granulomas, a reduced recruitment of lymphocytes and macrophages to the site of the infection and an increased influx of neutrophils. Our current data do not provide direct insight into how the attraction of lymphocytes and macrophages is impaired in and an experimental model of allergic asthma 10, 11 . Moreover, leukocyte activation was also inhibited by APC after renal and spinal cord injury in rats 6, 7, 41 . In addition, APC can inhibit the production of TNF-and other proinflammatory cytokines in only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From vitro and in vivo [6] [7] [8] [9] . The majority of the anti-inflammatory effects of APC in these models were unrelated to its anticoagulant effects. Our current data are also in accordance with recent findings in heterozygous protein C deficient mice, which demonstrated higher levels of proinflammatory cytokines and increased neutrophil invasion in their lungs after intraperitoneal injection of LPS 23 .
Notably, the present study contrasts with a previous investigation from our laboratory, in which the influence of the TM pro/pro mutation on the pulmonary coagulant and inflammatory response during acute lung inflammation models induced by intranasal administration with either bacterial respiratory pathogens or LPS was examined 15 . In that study we did not detect any difference between TM pro/pro and WT mice in either of these models, although in pneumococcal pneumonia fibrin deposition was modestly increased in TM pro/pro mice 15 . Thus, TM and APC apparently have a greater impact on the inflammatory reaction in the lung during chronic lung infection such as in murine tuberculosis. Alternatively, the influence of the TM pro/pro mutation on lung inflammation may be determined by the type of respiratory pathogen.
Conway et al. recently reported several anti-inflammatory properties of endogenous
TM that were unrelated to its anticoagulant properties 42 . These authors generated mice that lack the NH 2 -terminal (lectin) domain of TM; these TM LeD/LeD mice were shown to have normal TM antigen levels and to retain the capacity to generate APC. For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From inflammatory properties that can be dissected from the anticoagulant properties of TM 42 . It should be noted that although the TM pro/pro mice used here have an intact TM lectin domain, they have a diminished antigenic expression of TM 16 . Hence, TM pro/pro mice not only have a severely impaired capacity to generate APC, they also display an overall relative TM deficiency including the function of the TM lectin domain.
Therefore, our data do not definitively establish that the phenotype of TM pro/pro mice in this model of chronic infection is solely attributable to a reduced capacity to generate APC. In addition, the fact that the TM pro/pro mutation has a profound impact on the lung inflammatory response in spite of the fact that the overall pulmonary TM expression was strongly reduced as a consequence of M. tuberculosis infection suggests that even the presence of low TM levels is important for the regulation of lung inflammation during tuberculosis. Alternatively, and not mutually exclusive, TM at remote sites and/or in the systemic vasculature may affect lung inflammation, possibly by delivering APC. Another way by which TM deficiency may affect inflammatory reactions is by negatively influencing the activation of thrombinactivatable fibrinolysis inhibitor (TAFI). Indeed, TM is a critical cofactor for thrombin-mediated activation of TAFI 43 . TAFI not only inhibits fibrinolysis by impeding the conversion of plasminogen into plasmin, but also may exert antiinflammatory effects by virtue of its ability to inactivate complement factors C3a and The TM pro/pro mutation has no effect on coagulation during tuberculosis.
TATc levels in plasma and lung homogenates. Mice were intranasally infected with 
